Electronic Poster: Physics track: Treatment planning: applicationsEP-1543: Dominant intraprostatic lesions boosting: comparison of tomotherapy, VMAT and IMPT
Sign Up to like & getrecommendations! Published in 2017 at "Radiotherapy and Oncology"
DOI: 10.1016/s0167-8140(17)31978-3
Abstract: For patients with recurring prostate cancer around 90% of relapses occur at the location of the primary tumor. That motivates further local dose escalation to avoid enhanced doses to rectum and bladder. Boosting the dominant… read more here.
Keywords: vmat impt; intraprostatic lesions; physics; dominant intraprostatic ... See more keywords
Simultaneous Integrated Radiotherapy Boost to the Dominant Intraprostatic Lesion: Final Results of a Phase I/II Trial
Sign Up to like & getrecommendations! Published in 2020 at "AntiCancer Research"
DOI: 10.21873/anticanres.14672
Abstract: Background/Aim: Late toxicity and long-term outcomes of a phase I-II trial on patients with prostate cancer treated with an integrated boost to the dominant intraprostatic lesion (DIL) are reported. Patients and Methods: Patients were treated… read more here.
Keywords: intraprostatic lesion; boost; toxicity; boost dominant ... See more keywords
Protocol of the integrated boost to the dominant intraprostatic nodule in stereotactic body radiation therapy for localized prostate cancer.
Sign Up to like & getrecommendations! Published in 2022 at "Future oncology"
DOI: 10.2217/fon-2022-0590
Abstract: Aim: To explore the safety and efficacy of the integrated boost to the dominant intraprostatic nodule (DIN) based on 68Ga prostate-specific membrane antigen PET/MRI in stereotactic body radiation therapy (SBRT) for patients with localized prostate… read more here.
Keywords: boost dominant; stereotactic body; prostate; intraprostatic nodule ... See more keywords